Free Trial
NASDAQ:XDNA

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Price, Holdings, & News

Kelly CRISPR & Gene Editing Technology ETF logo
$7.38 0.00 (0.00%)
As of 07/25/2025

About Kelly CRISPR & Gene Editing Technology ETF (NASDAQ:XDNA)

Key Stats

Today's Range
$7.38
$7.38
50-Day Range
$7.38
$7.38
52-Week Range
$5.87
$11.83
Volume
N/A
Average Volume
3,034 shs
Market Capitalization
$2.21 million
Assets Under Management
$2.58 million
Dividend Yield
0.12%
Net Expense Ratio
0.78%
Aggregate Rating
N/A

ETF Overview

Kelly CRISPR & Gene Editing Technology ETF Expenses

TypeXDNATheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.78%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.57%0.56%0.52%0.56%
Total Expense0.78%0.74%0.76%0.73%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.78%0.60%0.63%0.63%0.60%
Receive XDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kelly CRISPR & Gene Editing Technology ETF and its competitors with MarketBeat's FREE daily newsletter.

XDNA ETF News Headlines

AI Frenzy Could Send ‘EarnPhone’ Soaring
The hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.
K-12 Genome Editing at Only $2 a Pop
See More Headlines

XDNA ETF - Frequently Asked Questions

Kelly CRISPR & Gene Editing Technology ETF's stock was trading at $7.38 at the beginning of the year. Since then, XDNA stock has increased by 0.0% and is now trading at $7.38.

Shares of XDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kelly CRISPR & Gene Editing Technology ETF investors own include Meta Platforms (META), RTX (RTX), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Cloudflare (NET), Birkenstock (BIRK) and Baidu (BIDU).

Fund Details

Issuer
Kelly Strategic Management
Fund Name
Kelly CRISPR & Gene Editing Technology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:XDNA
Inception Date
1/12/2022
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Strategic CRISPR & Gene Editing Technology Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
2

Fund Statistics

Assets Under Management
$2.58 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Kelly Strategic Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Jane Street

Miscellaneous

Beta
0.92
Creation Unit
25,000
Creation Fee
$250.00
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 3 XDNA Holdings

  • First American Government Obligations Fund
    Holding Weight: 49.96%
  • First American Treasury Obligations Fund
    Holding Weight: 49.96%
  • DEPOSITS WITH BROKER FOR SHORT POSITIONS
    Holding Weight: 0.09%

This page (NASDAQ:XDNA) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners